Relmada Therapeutics, Inc. focuses on developing therapies aimed at improving patient outcomes through durable efficacy, favorable safety, and ease of administration. The company is involved in drug development, including discovery, clinical development, regulatory strategy, and commercialization. Its team has extensive experience in the biopharmaceutical sector, and it aims to enable broad clinical adoption of its therapies.
